OTC Markets OTCPK - Delayed Quote USD

CV Sciences, Inc. (CVSI)

0.0254

-0.0012

(-4.66%)

At close: June 6 at 3:51:04 PM EDT

CV Sciences, Inc. Reports First Quarter 2025 Financial Results

SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients ...

ACCESS Newswire 23 days ago

CVSI
-4.66%
CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025

SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 /CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients ...

ACCESS Newswire 28 days ago

CVSI
-4.66%
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients ...

ACCESS Newswire 2 months ago

CVSI
-4.66%
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods

The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" ...

ACCESS Newswire 2 months ago

CVSI
-4.66%
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 /CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ...

ACCESS Newswire 2 months ago

CVSI
-4.66%
CV Sciences Unveils New Aura Collection THC Fizz Tablets

The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", ...

ACCESS Newswire 3 months ago

CVSI
-4.66%
CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has entered into a definitive agreement (the "Purchase Agreement") to acquire Extract Labs, Inc. ("Extract Labs"), a leading manufacturer and distributor of premium cannabinoid products including gummies, topicals and tinctures. Extract Labs branded produc

PR Newswire 6 months ago

CVSI
-4.66%
CV Sciences, Inc. Reports Third Quarter 2024 Financial Results

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2024.

PR Newswire 6 months ago

CVSI
-4.66%
CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the third quarter ended September 30, 2024, before the stock market opens on Thursday, November 14, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern

PR Newswire 6 months ago

CVSI
-4.66%
CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusHLTH™, an all-new line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance, and increased vitality. Rooted in rigorous science and fortified by clinically proven wellness ingredients, the

PR Newswire 9 months ago

CVSI
-4.66%
CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2024.

PR Newswire 9 months ago

CVSI
-4.66%
CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the second quarter ended June 30, 2024, before the stock market opens on Tuesday, August 13, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time)

PR Newswire 9 months ago

CVSI
-4.66%

Performance Overview

Return	CVSI	S&P 500 (^GSPC)
YTD	-15.47%	+2.02%
1-Year	-71.82%	+12.09%
3-Year	-36.60%	+45.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CV Sciences, Inc. (CVSI)

CV Sciences, Inc. Reports First Quarter 2025 Financial Results

CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025

CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results

CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods

CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

CV Sciences Unveils New Aura Collection THC Fizz Tablets

CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs

CV Sciences, Inc. Reports Third Quarter 2024 Financial Results

CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024

CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

Performance Overview